Inhibitor of DNA binding (Id) proteins play important roles in regulating cardiac development via paracrine signaling. Id1/Id3 knockout mice die at mid-gestation with multiple cardiac defects. Single Id knockout studies have not reported cardiomyopathies. To bypass embryonic lethality we used Tie2CRE-mediated recombination to conditionally delete Id1 against global Id3 ablation (Id cDKOs), which develops adult-onset dilated cardiomyopathy. We confirm upregulation of thrombospondin-1 (TSP1) in Id cDKO hearts. Colocalization studies reveal increased TSP1 expression in the vicinity of endothelial cells and near regions of endocardial fibrosis/disruption. Downstream fibrotic molecules were upregulated. Endocardial capillary density was reduced with evidence of vascular distention.
Microarray analysis of 5-6 month old Id cDKO hearts revealed dysregulation of angiogenic, fibrotic and hypertrophic markers 4 .
Methods
Genotyping and Mouse Colonies. Mice harboring flox insertions flanking the Id1 gene were crossed with mice with null mutations in Id1 and Id3 to generate Id1 F/F id3 −/− and Id1 F/− Id3 −/− (Id control mice). Id control mice were then crossed against Tie2Cre mice through a series of successive breedings to ultimately yield Tie2Cre+Id1 F/F id3 −/− and Tie2Cre+Id1 F/− Id3 −/− mice (Id cDKO). For verification of Cre/LoxP recombination, B6;129S3-Gt(ROSA)26Sor tm1Sor /J mice were crossed with breeding intermediates. For bone marrow transplantation studies, GFP transgenic mice, C57BL/6-Tg(UBC-GFP)30Scha/J were crossed with Id control and Tie2Cre intermediates to generate GFP-labeled Id control and Id cDKO mice. All mice used in experiments were congenic and possessed the C57BL/6J genetic background except for Tie2Cre mice, which were backcrossed 8-10 times against a pure C57BL/6J background to achieve >99% background purity. Genotyping PCR was performed using previously established primers and protocols 4, 5 . All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Rutgers New Jersey Medical School and performed in accordance with relevant guidelines and regulations.
Cardiac Explant Culture. Freshly isolated mouse hearts were immediately cut into 1mm transverse sections using sterilized cutting blades with a cutting matrix. Sections were rinsed in 1X DPBS and placed in serum starvation medium (low glucose DMEM supplemented with 1 mg/mL BSA with no FBS) for 1 hr. For the serum incubation experiment, sections were incubated in serum starvation medium supplemented with 2% mouse serum isolated from different mice. For experiments using recombinant proteins and peptides, sections were treated with serum starvation medium supplemented with 20 μM LSKL (Anaspec), 125 ng/mL recombinant TSP1 (R&D), 500 ng/mL recombinant IGFbp3 (R&D) and 200 ng/mL TSP1 Ab (Neomarkers). Cardiac explants were incubated at 37 °C for 6 hrs with 5% CO 2 under rocking conditions. Following treatment, the supernatant was collected and centrifuged at 900 g at 4 °C to isolate the cells in suspension. The resulting cell pellet was washed in 1X PBS, snap frozen in liquid nitrogen and submerged in Trizol reagent (Invitrogen). Cardiac explants were also snap frozen in liquid nitrogen and suspended in Trizol reagent. Trizol reagent was also added directly to the well to isolate RNA from the adhering cells at the bottom of the well. Trizol fractions were combined and subsequently processed to extract total RNA following manufacturer's protocol.
Bone Marrow Transplantation.
After clearing away muscle tissue, femurs and tibias were rinsed in 70% ethanol followed by 1X PBS wash. Total bone marrow cells were freshly isolated by flushing the femurs and tibias of mice from each study group using a 27G1½ PrecisionGlide needle (Becton-Dickinson) with IMDM (Invitrogen) supplemented with 2% FBS (Invitrogen). Debris was removed by straining the cells through a 40 μM nylon cell strainer (BD Falcon). Cells were centrifuged at 2000 rpm (900 × g) for 10 mins at 4 °C. Cells were subsequently resuspended and counted using a hemacytometer (Bright-Line). 5 × 10 6 bone marrow cells were resuspended in 100 μL 1× PBS and injected into the retroorbital sinus using a 27G1½ PrecisionGlide needle. Bone marrow injections were performed under isoflurane anesthesia (3% isoflurane in oxygen) under sterile conditions. Prior to bone marrow transplantation, recipient mice were first lethally irradiated with 11 Gray (Gy) of radiation from a Cesium-137 (Cs-137) dual source to ablate the endogenous bone marrow cells. Efficacy of irradiation was assessed by designating one mouse as an irradiation control, which does not receive bone marrow injection. These mice typically die off between 10-20 days post irradiation. Efficiency of reconstitution was checked at varying points post-transplantation by quantifying percentage of GFP positive cells per total number of gated cells. 95-100% donor cell incorporation was deemed full reconstitution. Following transplantation, mice were given autoclaved acidified (pH 2.3) water supplemented with enrofloxacin (Baytril) at a dosage of 600 μL per 1 L of volume for up to one month post-transplantation. In the correction study, Id cDKO recipients were transplanted with WT donor bone marrow cells to create 'forward transplanted' or FBMT mice. Conversely, in the dysregulation study, WT recipients were transplanted with GFP donor bone marrow cells to create 'reverse transplanted' or RBMT mice. LSKL Injection. LSKL (Anaspec) was injected into the retroorbital sinus at a dosage of 4 μg per gram of mouse body weight. Mice were then sacrificed 6 hours after the injection and tissue were acquired for further analysis.
Statistical Analysis. Data are presented as the mean ± s.e.m. (standard error of the mean). Statistical analysis was performed using the GraphPad Prism 5 Software. Independent t-tests were performed for comparisons between two groups. One-way ANOVA was performed for comparisons across multiple groups. The probability level of p < 0.05 was considered to be statistically significant. All experiments were performed in triplicate.
Results

Activation of TSP1/CTGF/collagen in Id cDKO hearts.
Based on microarray studies from prior studies 4 , we identified significant upregulation of thrombospondin-1 (TSP1) in Id cDKO hearts. TSP1 mRNA levels were found to be increased 2.93 ± 0.54-fold (p = 0.01) in Id cDKOs relative to WT hearts ( Fig. 1A) . No significant differences in TSP1 mRNA expression were observed between Id control and WT hearts while Id cDKO cardiac TSP1 levels were found to be significantly higher than Id control levels (p = 0.01) ( Fig. 1A) . These trends were confirmed by western blot analysis, demonstrating a 3.9 fold increase in TSP1 protein levels relative to WT levels ( Fig. 1B) . Connective tissue growth factor (CTGF), a secreted protein found to be strongly upregulated in heart failure 6, 7 was elevated 5.95 ± 0.89-fold (p = 0.009) relative to WT levels ( Fig. 1A) . No significant differences in CTGF expression were observed between Id control and WT hearts although a significant difference was found between Id cDKO and Id control hearts (p = 0.002). Collagen I (Col1a1) mRNA levels were observed to be upregulated 4.12 ± 1.12-fold (p = 0.08) relative to WT levels ( Fig. 1A ). No significant differences were observed between WT and Id control hearts although Id cDKO hearts showed a significant elevation in Col1a1 mRNA levels compared to id control levels (p = 0.03). Collagen III (Col3A1) mRNA levels were also found to be significantly upregulated 3.30 ± 1.12-fold (p = 0.03) in Id cDKO hearts relative to WT hearts ( Fig. 1A ). No significant difference was detected between WT and Id control hearts although a significant difference was observed between Id cDKO and Id control hearts (p = 0.007). Taken together, these results suggest activation of the TSP1/CTGF/ collagen pathway in Id cDKO hearts.
Defective endothelial network formation and localization of TSP1 upregulation in the vicinity of cardiac endothelial cells within the endocardium. Prior studies demonstrated that TSP1 serves
as an effector of the Id pathway and has an angiostatic effect on endothelial cells 8, 9 , Analysis of CD31 immunostained cardiac sections revealed a marked decrease in capillary density within the endocardium that was observed as early as 2 months of age but was significant by 5-6 months of age (p < 0.01) ( Fig. 2A ). This decrease in capillary density and observed defect in endothelial network is congruent with TSP1's known angiostatic effect.
To determine the pattern of TSP1 expression within the Id cDKO heart, cardiac sections were stained with the anti-TSP1 antibody Ab-4 (clone A6.1). TSP1 immunostains demonstrated a pattern that was interstitial and most heavily localized to the endocardium and endomyocardium (Fig. 2B ). In particular, TSP1 staining was observed near regions of endocardial disruption. Confocal microscopy on CD31/TSP1 dual-stained sections of Id cDKO hearts revealed foci of TSP1 in the immediate vicinity of CD31 positive endothelial cells (Fig. 2B ). These findings demonstrate that TSP1 expression in Id cDKO hearts is localized to endothelial cells mostly within the endocardial regions.
Increased apoptosis in 5-6 month old Id cDKO hearts.
Prior studies have shown that TSP1 not only exerts angiostatic effects but also induces apoptosis by activating the downstream caspase death pathway 10, 11 . The upregulation of TSP1 in Id cDKO hearts raises the question of whether TSP1 may be playing an apoptotic role in this system. Quantitative TUNEL analysis revealed that while no significant differences in apoptosis were observed across the three groups (WT, Id control, Id cDKO) at 2-4 months of age, a significant increase in TUNEL positive cells were detected at 5-6 months of age ( Fig. 3A) . Western blot analysis of Id cDKO hearts revealed an overall increase in Bax protein level (3.8 fold increase compared to WT levels) but no significant A one-way ANOVA was used to test for differences in mRNA expression amongst the three groups. Data presented as fold change relative to WT levels. mRNA levels were significantly different across the three group for the following markers: Thrombospondin-1 (TSP1): F (2, 12) = 6.12, p = 0.01; connective tissue growth factor (CTGF): F (2, 12) = 11.05, p = 0.002; collagen I (Col1a1): F (2, 12) = 4.07, p = 0.04; collagen III (Col3a1): F (2, 12) = 6.07, p = 0.02. *p < 0.05; **p < 0.01 (B) Representative western blot for TSP1 in 6 month old WT and Id cDKO hearts, and quantification. Protein levels were normalized to GAPDH. Quantitation provided on right panel is expressed as ratios denoted on x-axis. Data presented as fold change relative to WT levels. changes in Bcl-2 or Bcl-xL levels (Fig. 3B ). Taken together, these results suggest that Id cDKO hearts develop evidence of increased apoptosis at later stages of adult life.
Transfer of Id null bone marrow cells into WT recipients (R-BMT) leads to development of endomyocardial fibrosis.
Because Tie2 is also expressed in hematopoietic cells and a number of hematopoietic defects (e.g., anemia and splenomegaly) were apparent in Id cDKO mice 4 , the question arises as to whether hematopoietic Id contributes to the dilated cardiomyopathy observed in Id cDKO mice. To address this question, a series of bone marrow transplantations were performed to control the Id status of the bone marrow cells. In the forward transplantation setup (FBMT), lethally irradiated Id cDKO recipients were transplanted with WT bone marrow donor cells and subsequently observed for evidence of phenotypic rescue. In the reverse transplantation setup (RBMT), lethally irradiated WT recipients were transplanted with Id cDKO bone marrow donor cells and subsequently observed for evidence of pathology. Full reconstitution occurred. Histological analysis of hearts from WTBMT (wild type recipients of wild type bone marrow) and RBMT mice at 6 months of age (4 months post transplantation) revealed evidence of cardiac fibrosis in the endomyocardium of RBMT hearts reminiscent of the cardiac fibrosis observed in Id cDKO hearts with areas of endocardial disruption and interstitial fibrosis (Fig. 4A ). Evidence of cardiac pathology was found in 62% of RBMTs (Suppl. Table 1 ). Total collagen content in RBMT was not different from that of WTBMT (0.52 ± 0.07 μg hydroxyproline/mg left ventricle compared to 0.63 ± 0.07 μg hydroxyproline/mg left ventricle respectively, p = 0.13). 70% of FBMTs demonstrated evidence of cardiac disease (Suppl. Table 1 ). Penetrance of pathology does not appear to correlate with disease severity in the donor. Heart weight/body weight ratio showed a non-significant trend towards higher levels in both RBMT and FBMT mice compared to WTBMT controls (Fig. 4B ). Parameters of cardiac function were not significantly different in RBMT and FBMT mice compared to WTBMT (Fig. 4C and D) . To test this question, an ex vivo cardiac explant experiment was developed in which 1 mm sections of WT hearts were incubated with 2% serum obtained from WT and Id cDKO mice under rocking conditions at 37 °C in 5% CO 2 for 5 hrs after which point RNA was extracted for real time PCR analysis (Fig. 5A) . While no significant differences in TSP1 expression were apparent, CTGF and Col3A1 were upregulated by 2.23 ± 0.01 fold (p < 0.01) and 6.93 ± 0.93 fold (p < 0.05) respectively (Fig. 5A) .
The observation of incipient cardiac fibrosis in RBMTs reminiscent of the cardiac fibrosis observed in Id cDKOs leads to the question of whether the same TSP1/CTGF/collagen cascade of molecular events is activated in RBMT hearts. RT PCR analysis of hearts from bone marrow transplanted mice revealed a 1.71 ± 0.18 fold increase in TSP1 expression in RBMT vs. WTBMT levels (p = 0.02) ( Fig. 5B ). CTGF expression was significantly increased 2.48 ± 0.07 fold (p = 0.05) in RBMT hearts (Fig. 5B ). Increased expression of Col3A1 by a fold change of 1.85 ± 0.20 (p = 0.0003) was detected in RBMT hearts (Fig. 5B ). No significant changes in Col1A1 were observed. Western blot analysis confirmed 1.76 ± 0.21 fold increase (p = 0.05) in TSP1 protein levels in RBMT hearts relative to WTBMT levels (Fig. 5C ). Conversely, western blot analysis revealed a trend towards decreased TSP1 protein levels (0.52 ± 0.22 fold decrease, p = 0.37) in FBMT hearts compared to WTBMT hearts. TSP1 protein levels were significantly increased in RBMT hearts compared to FBMT hearts. Together these findings suggest that TSP1/CTGF/collagen are activated in RBMT hearts. 
Injection of LSKL in Id cDKO mice antagonizes TSP1 expression and leads to downregulation of collagen.
To determine whether activation of the TSP1/CTGF/collagen pathway can be antagonized at the level of TSP1's known interaction with TGFβ, 2 month old Id cDKO mice were given LSKL (Anaspec), a known peptide inhibitor of TSP1 that selectively disrupts TSP1-dependent TGFβ activation [12] [13] [14] [15] . RT PCR analysis revealed that LSKL injected Id cDKO hearts demonstrated a 3.61 ± 0.19 (p < 0.05) reduction in Col1A1 expression compared to non-LSKL injected controls (Fig. 6A ). mRNA expression of TGFβ2, TGFβ3 and Col3A1 were not significantly altered. Western blot analysis for Col1A1 revealed a significant 20% reduction in Col1A1 protein level in LSKL injected Id cDKO mice compared to non-LSKL injected control levels (Fig. 6B ). These trends were tested ex vivo using a cardiac explant culture system where 1 mm transverse cardiac sections from WT, Id control and Id cDKO mice were incubated in 20 μM LSKL at 37 °C for 6 hrs with 5% CO 2 under rocking conditions. RNA was subsequently extracted and analyzed via real-time quantitative PCR. CTGF mRNA expression showed a significant 2.62 ± 0.53 fold reduction (p < 0.05) in Id cDKO treated with LSKL vs. untreated controls. Col3A1 mRNA expression showed a significant 2.15 ± 0.18 fold reduction (p < 0.05) in Id cDKO treated with LSKL vs. untreated controls. A trend towards decreased expression of Col1A1 was observed in Id cDKO treated with LSKL vs. untreated control but was not statistically significant (Fig. 6C ).
Discussion
While Id double knockout mice die at midgestation with numerous cardiac defects, prior single Id knockout studies have not yet reported any significant cardiac phenotypes. This observation coupled with the finding that Id1 and Id3 are expressed in overlapping patterns within the embryo 16 suggest that dual Id1 and Id3 deletion accomplished through the Tie2Cre/loxP system effectively eliminated Id compensation in a layer specific manner (endothelium, endocardium). These mice survived into adulthood and developed a distinct fibrotic cardiomyopathy phenotype characterized by endocardial and endomyocardial disruption and fibrosis, reduced cardiac function, hypertrophic changes and increased perivascular fibrosis 4 . Aged 12-14 month old Id1 knockout mice lacking three alleles of Id (Id1 −/− Id3 +/− ) do not exhibit signs of cardiac pathology. Conversely, aged 12-14 month old Id control mice (Id1 F/− Id3 −/− ) develop signs of cardiac disease characterized by endocardial fibrosis reminiscent of early Id cDKO pathology, suggesting that Tie2Cre mediated ablation of Id compensation results in acceleration of cardiac pathology as Id cDKO hearts typically present with fulminant pathology by 6 months of age. The observation of mice with only a single functional allele of Id3 do not exhibit evidence of cardiac disease while mice with only a single functional allele of Id1 do exhibit early signs of cardiac disease at an advanced aged suggests that while Id1 and Id3 may compensate, the degree to which the two Id members functionally compensate may differ.
Through this study, Id cDKO hearts were shown to overexpress TSP1 with a pattern of distribution that appears interstitial, localizing to endothelial cells with increased concentration in the endocardial region near regions of disruption. In light of prior evidence that Id1 represses TSP1 transcription to mediate the process of angiogenesis 8 , these findings coupled with the observation of decreased CD31 density within the endocardium suggest that loss of Id1 repression leads to increased TSP1 expression may in turn play a role in defective vascularization of Id cDKO hearts. Prior reports have demonstrated that TSP1 mediates apoptosis through activation of the Bax/Bcl-2/caspase 3 pathway in endothelial cells 10, 17, 18 . Our studies reveal increased levels of apoptosis in Id cDKO hearts. Whether this observed pattern of increased apoptosis is endothelial remains to be determined.
Reports of TSP1's role in cardiac fibrosis remain controversial and highly context dependent 14, [19] [20] [21] [22] [23] . In this system of Id loss, TSP1 appears to contribute in part to the fibrotic phenotype observed through TSP1-dependent activation of TGFβ and downstream upregulation of CTGF and collagens. Direct antagonism of this interaction between TSP1 and TGFβ using LSKL (an inhibitory peptide derived from latency associated peptide) appears to block this cascade with evidence of reversal of CTGF and collagen expression patterns. Whether a similar effect can be achieved in vivo through selective agents targeting downstream members of this cascade remains to be determined. To address the fact that Tie2 targets both hematopoietic and endothelial cell lineages and determine whether the hematopoietic defects observed in Id cDKOs contribute to the observed cardiomyopathy, a series of bone marrow transplantation experiments were performed. Roughly 62% of RBMTs demonstrated evidence of incipient cardiac pathology reminiscent of the Id cDKO cardiac pathology. Cardiac function was not compromised at 4 months post-transplantation. Future long-term follow-up studies will help determine whether cardiac pathology becomes evident and cardiac function declines over time. The bone marrow transplantation results suggest that the absence of Id signaling in the blood can partially trigger fibrosis in endomyocardial regions of a WT heart. The effect of RBMT in the heart, however, is milder compared to that of the Tie2CRE Id cDKO mice. The mild fibrotic phenotype could be due to the fact that the hematopoietic but not the endothelial lineage is Id-defective in the RBMT, and also due to the fact that the switch from Id positive to Id negative in RBMT takes place at 2 months, while in Id cDKO mice it takes place well before during mid-gestation development. Increased expression of TSP1, CTGF, Col1A1 and Col3A1 suggest that TSP1/TGFβ/CTGF/collagen are activated in RBMT hearts. Whether injection of agents like LSKL that disrupt this signaling cascade into RBMT mice can help prevent the emergence of cardiac pathology remains to be determined. While anemia may contribute to the cardiac disease over time, RBMT mice develop evidence of cardiac disease in the absence of anemia, suggesting that anemia in this system may not contribute significantly to the development of this cardiac phenotype.
We have previously described a non-cell autonomous role for the mode of action of Id genes, in particular in the developing heart. The Id genes govern the expression of short-and long-range secreted factors, including Wnt5a and IGF-1 respectively 3, 24 . In the absence of Id1 and Id3 genes, IGF-1 is downregulated in the developing epicardium, which directly affects the proliferation rate of the developing myocardium at mid-gestation. Intraperitoneal injection of IGF-1 into mothers harboring Id1Id3 KO embryos partially rescues the lethal cardiac phenotype. In this report, we established a link between loss of Id in the hematopoietic system and upregulation of TSP-1, a known target of Id genes 8 , in the myocardium, with direct consequences in endomyocardial pathology and downstream fibrotic factors. Whether the soluble factor that bridges Id loss distally and upregulation of TSP is IGF-1, it remains to be further elucidated. These findings may have significant clinical implications for screening of bone marrow donors in the assessment of long-term safety of bone marrow transplantation therapies. 
